MERICA ANGE: Open Payments
NPI 1740902568 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,256 in 20 payments from 9 companies in 2025. Trend: 2023 $692 · 2024 $689 · 2025 $1,256
Food & beverage: $1,181Education: $75
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $274 |
| Madrigal Pharmaceuticals | 2 | $271 |
| ABBVIE INC. | 6 | $231 |
| Ardelyx, Inc. | 2 | $152 |
| Phathom Pharmaceuticals, Inc. | 1 | $125 |
| Medtronic, Inc. | 1 | $120 |
| Novo Nordisk Inc | 1 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: TREMFYA, REZDIFFRA, SKYRIZI, IBSRELA, VOQUEZNA, ENDOFLIP, RINVOQ, XIFAXAN.
Industry payments across FL — which companies pay providers there.
